Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

Saved in:
Bibliographic Details
Published inAmerican journal of hematology Vol. 95; no. 9; pp. E235 - E238
Main Authors Cao, Xin‐Xin, Li, Jian, Zhao, Ai‐Lin, He, Tian‐Hua, Gao, Xue‐Min, Cai, Hua‐Cong, Zhang, Lu, Zhang, Yan, Feng, Jun, Zhu, Tie‐Nan, Niu, Na, Sun, Jian, Liang, Zhi‐Yong, Duan, Ming‐Hui, Zhou, Dao‐bin
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.09.2020
Wiley Subscription Services, Inc
Subjects
Adolescent
Adult
Aged
Autoimmune diseases
Cytarabine
Cytarabine - administration & dosage
Cytarabine - adverse effects
Disease-Free Survival
Drug Therapy, Combination
Female
Hematology
Histiocytosis
Histiocytosis, Langerhans-Cell - diagnosis
Histiocytosis, Langerhans-Cell - drug therapy
Histiocytosis, Langerhans-Cell - mortality
Humans
Langerhans cell histiocytosis
Male
Methotrexate
Methotrexate - administration & dosage
Methotrexate - adverse effects
Middle Aged
Prospective Studies
Survival Rate
Online AccessGet full text

Cover

More Information
Bibliography:Funding information
These authors contributed equally to this work.
National Key Research and Development Program of China; Innovation Fund; Chinese Academy of Medical Sciences
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.25864